Cargando…

Drug screening using the sweat of a fingerprint: lateral flow detection of Δ(9)-tetrahydrocannabinol, cocaine, opiates and amphetamine

Here, we describe the use of a fluorescence based lateral flow competition assay for the screening of four classes of drugs, viz, Δ(9)-tetrahydrocannabinol (THC), cocaine (through the detection of benzoylecgonine, BZE), opiates (through the detection of morphine, MOR) and amphetamine (AMP) present i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hudson, Mark, Stuchinskaya, Tanya, Ramma, Smita, Patel, Jalpa, Sievers, Claudia, Goetz, Stephan, Hines, Selina, Menzies, Eleanor, Russell, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380464/
https://www.ncbi.nlm.nih.gov/pubmed/30272189
http://dx.doi.org/10.1093/jat/bky068
_version_ 1783396306788548608
author Hudson, Mark
Stuchinskaya, Tanya
Ramma, Smita
Patel, Jalpa
Sievers, Claudia
Goetz, Stephan
Hines, Selina
Menzies, Eleanor
Russell, David A
author_facet Hudson, Mark
Stuchinskaya, Tanya
Ramma, Smita
Patel, Jalpa
Sievers, Claudia
Goetz, Stephan
Hines, Selina
Menzies, Eleanor
Russell, David A
author_sort Hudson, Mark
collection PubMed
description Here, we describe the use of a fluorescence based lateral flow competition assay for the screening of four classes of drugs, viz, Δ(9)-tetrahydrocannabinol (THC), cocaine (through the detection of benzoylecgonine, BZE), opiates (through the detection of morphine, MOR) and amphetamine (AMP) present in the sweat of a fingerprint. The Drug Screening Cartridge was specifically developed for fingerprint sample collection and analysis. For this study, the cut-offs were set at: 190, 90, 68 and 80 pg/fingerprint for THC, BZE, MOR and AMP, respectively. Working with three UK coroners, the Drug Screening Cartridge, together with its fluorescence reader, was applied to the detection of drugs in the sweat of a fingerprint from deceased individuals. The study shows that there was sufficient sweat present on the fingertips to enable analysis and that the Drug Screening Cartridge could detect the presence, or absence, of each drug. The presence of the drugs was confirmed using LC–MS-MS analysis of a second fingerprint sample collected simultaneously. Excellent correlation was achieved between the results obtained from the Drug Screening Cartridge and the LC–MS-MS analysis of the fingerprint samples obtained from 75 individuals. The accuracy of the results was: 99% for THC; 95% for BZE; 96% for MOR and 93% for AMP. The results obtained using the Drug Screening Cartridge were also compared to toxicological analysis of blood and urine samples with good correlation. The accuracy of the results between the Drug Screening Cartridge and blood was: 96%, 92%, 88% and 97% for THC, BZE, MOR and AMP, respectively. The comparison with urine showed an accuracy ranging between 86% and 92%. This fingerprint sample method has a collection time of just 5 s and a total analysis time of <10 mins. These results show that the lateral flow Drug Screening Cartridge is an excellent screening test to provide information on drug use from the sweat in a single fingerprint sample.
format Online
Article
Text
id pubmed-6380464
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-63804642019-02-22 Drug screening using the sweat of a fingerprint: lateral flow detection of Δ(9)-tetrahydrocannabinol, cocaine, opiates and amphetamine Hudson, Mark Stuchinskaya, Tanya Ramma, Smita Patel, Jalpa Sievers, Claudia Goetz, Stephan Hines, Selina Menzies, Eleanor Russell, David A J Anal Toxicol Article Here, we describe the use of a fluorescence based lateral flow competition assay for the screening of four classes of drugs, viz, Δ(9)-tetrahydrocannabinol (THC), cocaine (through the detection of benzoylecgonine, BZE), opiates (through the detection of morphine, MOR) and amphetamine (AMP) present in the sweat of a fingerprint. The Drug Screening Cartridge was specifically developed for fingerprint sample collection and analysis. For this study, the cut-offs were set at: 190, 90, 68 and 80 pg/fingerprint for THC, BZE, MOR and AMP, respectively. Working with three UK coroners, the Drug Screening Cartridge, together with its fluorescence reader, was applied to the detection of drugs in the sweat of a fingerprint from deceased individuals. The study shows that there was sufficient sweat present on the fingertips to enable analysis and that the Drug Screening Cartridge could detect the presence, or absence, of each drug. The presence of the drugs was confirmed using LC–MS-MS analysis of a second fingerprint sample collected simultaneously. Excellent correlation was achieved between the results obtained from the Drug Screening Cartridge and the LC–MS-MS analysis of the fingerprint samples obtained from 75 individuals. The accuracy of the results was: 99% for THC; 95% for BZE; 96% for MOR and 93% for AMP. The results obtained using the Drug Screening Cartridge were also compared to toxicological analysis of blood and urine samples with good correlation. The accuracy of the results between the Drug Screening Cartridge and blood was: 96%, 92%, 88% and 97% for THC, BZE, MOR and AMP, respectively. The comparison with urine showed an accuracy ranging between 86% and 92%. This fingerprint sample method has a collection time of just 5 s and a total analysis time of <10 mins. These results show that the lateral flow Drug Screening Cartridge is an excellent screening test to provide information on drug use from the sweat in a single fingerprint sample. Oxford University Press 2019-03 2018-10-01 /pmc/articles/PMC6380464/ /pubmed/30272189 http://dx.doi.org/10.1093/jat/bky068 Text en © The Author(s) 2018. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Article
Hudson, Mark
Stuchinskaya, Tanya
Ramma, Smita
Patel, Jalpa
Sievers, Claudia
Goetz, Stephan
Hines, Selina
Menzies, Eleanor
Russell, David A
Drug screening using the sweat of a fingerprint: lateral flow detection of Δ(9)-tetrahydrocannabinol, cocaine, opiates and amphetamine
title Drug screening using the sweat of a fingerprint: lateral flow detection of Δ(9)-tetrahydrocannabinol, cocaine, opiates and amphetamine
title_full Drug screening using the sweat of a fingerprint: lateral flow detection of Δ(9)-tetrahydrocannabinol, cocaine, opiates and amphetamine
title_fullStr Drug screening using the sweat of a fingerprint: lateral flow detection of Δ(9)-tetrahydrocannabinol, cocaine, opiates and amphetamine
title_full_unstemmed Drug screening using the sweat of a fingerprint: lateral flow detection of Δ(9)-tetrahydrocannabinol, cocaine, opiates and amphetamine
title_short Drug screening using the sweat of a fingerprint: lateral flow detection of Δ(9)-tetrahydrocannabinol, cocaine, opiates and amphetamine
title_sort drug screening using the sweat of a fingerprint: lateral flow detection of δ(9)-tetrahydrocannabinol, cocaine, opiates and amphetamine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380464/
https://www.ncbi.nlm.nih.gov/pubmed/30272189
http://dx.doi.org/10.1093/jat/bky068
work_keys_str_mv AT hudsonmark drugscreeningusingthesweatofafingerprintlateralflowdetectionofd9tetrahydrocannabinolcocaineopiatesandamphetamine
AT stuchinskayatanya drugscreeningusingthesweatofafingerprintlateralflowdetectionofd9tetrahydrocannabinolcocaineopiatesandamphetamine
AT rammasmita drugscreeningusingthesweatofafingerprintlateralflowdetectionofd9tetrahydrocannabinolcocaineopiatesandamphetamine
AT pateljalpa drugscreeningusingthesweatofafingerprintlateralflowdetectionofd9tetrahydrocannabinolcocaineopiatesandamphetamine
AT sieversclaudia drugscreeningusingthesweatofafingerprintlateralflowdetectionofd9tetrahydrocannabinolcocaineopiatesandamphetamine
AT goetzstephan drugscreeningusingthesweatofafingerprintlateralflowdetectionofd9tetrahydrocannabinolcocaineopiatesandamphetamine
AT hinesselina drugscreeningusingthesweatofafingerprintlateralflowdetectionofd9tetrahydrocannabinolcocaineopiatesandamphetamine
AT menzieseleanor drugscreeningusingthesweatofafingerprintlateralflowdetectionofd9tetrahydrocannabinolcocaineopiatesandamphetamine
AT russelldavida drugscreeningusingthesweatofafingerprintlateralflowdetectionofd9tetrahydrocannabinolcocaineopiatesandamphetamine